These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 5824278)

  • 1. Treatment of Schistosoma haematobium infection with astiban in Iraqis.
    Awkati A
    Trans R Soc Trop Med Hyg; 1969; 63(5):576-8. PubMed ID: 5824278
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral tracer sodium antimony-2, 3-meso-dimercapto-succinate (Astiban) in hamsters infected with Schistosoma mansoni.
    Girgis GR; Girgis NI; Schulert AR; McConnell E
    J Egypt Public Health Assoc; 1966; 41(4):237-42. PubMed ID: 6002838
    [No Abstract]   [Full Text] [Related]  

  • 3. Astiban therapy of urinary schistosomiasis: a quantitative evaluation.
    Farid Z; Bassily S; Schulert A; McConnell E
    Ann Trop Med Parasitol; 1966 Jun; 60(2):165-8. PubMed ID: 5962469
    [No Abstract]   [Full Text] [Related]  

  • 4. Suppressive therapy with MsbE and Astiban in hamsters infected with Schistosoma mansoni.
    Baldewsing R
    Trop Geogr Med; 1973 Jun; 25(2):174-8. PubMed ID: 4736841
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of Ciba 32644-Ba on Schistosoma haematobium.
    Davis A
    Acta Trop Suppl; 1966; 9():132-44. PubMed ID: 5219457
    [No Abstract]   [Full Text] [Related]  

  • 6. Intestinal schistosomiasis a comparative therapeutic trial.
    Abo-el-Enein Mel-S ; Sheir ZM; Amer ZM; el-Basousy E
    J Egypt Med Assoc; 1972; 55(1):69-75. PubMed ID: 4340485
    [No Abstract]   [Full Text] [Related]  

  • 7. Urological complications of endemic schistosomiasis in schoolchildren. 3. Follow-up studies at Donge School, Zanzibar.
    Macdonald G; Forsyth DM
    Trans R Soc Trop Med Hyg; 1968; 62(6):766-74. PubMed ID: 5729565
    [No Abstract]   [Full Text] [Related]  

  • 8. Two-year follow-up of patients with Schistosoma haematobium treated with stibocaptate; with particular reference to an attempt to determine the rate of reinfection.
    Jordan P
    Trans R Soc Trop Med Hyg; 1968; 62(3):413-7. PubMed ID: 5659235
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic use of dimercaptosuccinate of antimony and sodium (Astiban) in the treatment of Manson's schistosomiasis].
    Teixeira D; de Gouveia OF; Miyahira AR; Galper E; da Cunha MA
    Hospital (Rio J); 1965 Dec; 68(6):1361-75. PubMed ID: 5295283
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of urinary bilharziasis in a small focus with sodium antimony dimercaptosuccinate (astiban).
    Arfaa F; Tohidi E; Ardelan A
    Am J Trop Med Hyg; 1967 May; 16(3):300-3. PubMed ID: 6023686
    [No Abstract]   [Full Text] [Related]  

  • 11. [Sodium antimony-meso 2,3 dimercapto-succinate in intestinal schistosomiasis].
    de Oliveira C; de Mendonça LE
    Hospital (Rio J); 1968 Jan; 73(1):253-7. PubMed ID: 5308501
    [No Abstract]   [Full Text] [Related]  

  • 12. Pulmonary function in patients with early asymptomatic schistosomiasis before and after treatment with sodium antimony dimercaptosuccinate (Astiban).
    Fuleihan FJ; Abboud RT
    Am J Trop Med Hyg; 1968 May; 17(3):372-7. PubMed ID: 5652697
    [No Abstract]   [Full Text] [Related]  

  • 13. The carbohydrate metabolism of Schistosoma mansoni and some effects of ambilhar and astiban.
    Magzoub M; Fletcher KA; Maegraith BG
    Trans R Soc Trop Med Hyg; 1969; 63(1):16. PubMed ID: 5789093
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical experiences with antimonyl-dimethylcysteino-tartrate (NAP) in a rural population infected with Schistosoma mansoni.
    Pedrique MR; Barbera S; Ercoli N
    Ann Trop Med Parasitol; 1970 Jun; 64(2):255-61. PubMed ID: 5497392
    [No Abstract]   [Full Text] [Related]  

  • 15. Respiratory function in moderate schistosomal infection. Effect of chemotherapy.
    Fuleihan FJ; Habaybeh A; Abdallah A; Moussa AH; Saif M; Srougi M; Kent DC
    Am Rev Respir Dis; 1969 Nov; 100(5):651-61. PubMed ID: 5375282
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of urinary bilharziosis due to Schistosoma haematobium by antimony dimercaptosuccinate].
    FRIEDHEIM EA
    Bull Soc Pathol Exot Filiales; 1956; 49(6):1247-52. PubMed ID: 13426747
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic use of antimony and sodium dimercaptosuccinate in the treatment of schistosomiasis mansoni].
    Teixeira D; de Gouveia OF; Miyahira AR; Galper E; da Cunha MA
    Hospital (Rio J); 1965 Dec; 68(6):1361-75. PubMed ID: 5296034
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical evaluation of niridazole in Schistosoma haematobium and mansoni infections.
    Abdallah A; Saif M
    Ann N Y Acad Sci; 1969 Oct; 160(2):686-95. PubMed ID: 4898961
    [No Abstract]   [Full Text] [Related]  

  • 19. A new trend for controlling schistosomiasis in a hyperendemic area at iflaka, U.A. R., by elimination of the parasite from man and vector.
    Sherif AF
    J Egypt Public Health Assoc; 1968; 43(1):30-76. PubMed ID: 5728818
    [No Abstract]   [Full Text] [Related]  

  • 20. Astiban therapy of Schistosoma mansoni infection: a quantitative evaluation.
    Farid Z; Bassily S; McConnell E; Davis J
    Ann Trop Med Parasitol; 1967 Sep; 61(3):310-4. PubMed ID: 5625700
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.